FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: Seekingalpha
Browsing: Healthcare
Pfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapies Source: Seekingalpha
Virax stock rallies 22% on mpox detection kit deal Source: Seekingalpha
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity Source: Seekingalpha
US House committee sends warning letters to CVS, Cigna, UnitedHealth Source: Seekingalpha
Marijuana rescheduling unlikely to lead to cannabis banking reform Source: Seekingalpha
LivaNova rises following possible CMS reimbursement boost for vagus nerve stimulation Source: Seekingalpha
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 Source: Seekingalpha
Roth starts CG Oncology at purchase, cites anticipated FDA filing Source: Seekingalpha
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements Source: Seekingalpha